Orthopedic Device Market
The future of the global orthopedic device market looks promising with opportunities in the hip, knee, spine, dental, and craniomaxillofacial markets. The global orthopedic device market is expected to reach an estimated $126.8 million by 2035 from $87.2 million in 2027 with a CAGR of 4.8% from 2027 to 2035. The major drivers for this market are the growing demand for minimally invasive surgeries, the rising need for joint replacement surgeries, and the increasing aging population needing orthopedic treatments.
- Lucintel forecasts that, within the type category, joint reconstruction is expected to witness higher growth over the forecast period due to the increasing prevalence of orthopedic joint disorders.
- Within the application category, knee is expected to witness the highest growth over the forecast period due to the rising incidence of knee osteoarthritis cases.
- In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the improving healthcare infrastructure and aging population growth.
Emerging Trends in Orthopedic Device Market
The orthopedic device market will shift from a focus on volume to outcome by 2027. Aging populations create a growing demand. Meanwhile, changes in the way surgery is performed and integrated technologies shift the types of evidence needed. Lucintel has identified technology adoption and procedure migration as key drivers affecting the market.
- Outpatient Migration: The U.S. is leading joint replacement migration to the outpatient setting. CMS's 2025 payment policy provides a framework to encourage outpatient surgical procedures. Additionally, Stryker reported record 2024 orders for its Mako platform. It is expected that other device manufacturers will create smaller and faster technologies by 2030 to accommodate the shift to outpatient surgery.
- Robotic and Digital Surgery: Procedures with the assistance of robotic systems are expanding beyond knee surgeries to hip and spine surgeries. Intuitive Surgical reported that in 2024 they had installed over 2,300 da Vinci systems worldwide. Zimmer Biomet added ROSA to their portfolio in 2025. In the next five years, the use of software to plan surgeries will impact the kind of implants that surgeons use and their preferences.
- Personalized Implants: Additive manufacturing (AM) is transitioning from the use of non-patient specific components to patient-specific components. In 2024, 3D printing of medical devices was commercialized by Materialise, and the FDA cleared the production of porous titanium to be used in medical implants. In complex cases of reconstruction, AM implants will be used and will be priced higher than traditional implants.
- Value-based Procurement: Customers base their decisions on the total cost of an episode of care, the average length of stay of patients, and the time it takes to perform the surgery as opposed to the cost of a product. Hospitals will require that their suppliers provide them with evidence of the clinical outcomes of the product they wish to sell them, training of their staff on the use of the product, as well as the monitoring of the patients post-surgery.
- Biologics Integration: Orthopedic implant portfolios are integrating bone grafts and other regenerative products. The FDA continued clearing 510(k)s of absorbable and synthetic bone-graft substitutes in 2025. Though biologics accelerate the healing process, other barriers will limit their adoption.
It is predicted that the orthopedic implant market will grow, however, the growth will not be evenly distributed. Areas such as outpatient surgeries, robotics, and personalized manufacturing will provide the best opportunities for growth. Suppliers without evidence or the ability to provide clinical services will find their prices under pressure. Hospitals will want integrated solutions, while payers will want products or services that meet established outcomes. Surgeons will decide the outcome of products launched in the market.
Recent Developments in the Orthopedic Device Market
The orthopedic device market is entering a more active M&A cycle due to population aging, outpatient migration and robotic assistance. Funding will increase through 2027, as companies work to differentiate their products, such as implants, through software and economic models for ambulatory care. Lucintel expects that competition will be focused on clinical outcomes, the efficiency of the surgical team and control of hospital costs.
- Robotic Platform Expansion: Reaching 1 million procedures worldwide in 2025 strengthened Stryker's competitive position in the jvth replacement space with its Mako system. Competition over the next 3-5 years will largely be for dominance in the software and instrumentations space along with service revenue.
- Outpatient Manufacturing Investment: Continued focus on outpatient facilities and more streamlined product lines. Focus on outpatient implant offerings will continue. With Zimmer's commitment to outpatient facilities and other companies following suit, the focus on standardized implant trays and rapid turnover will continue.
- Implant Technology: U.S. Food and Drug Administration (FDA) clearances in 2025 allowed continued use of patient specific planning and additive manufacturing for orthopedic implants. In areas where revision surgery is needed or where the anatomy is not ideally suited for normal implant usage, these implants could be useful.
- Digital Partnerships: The combination of increased partnerships and the acquisition of imaging, navigation and artificial intelligence software in 2025 set the stage for a change in the implantable device industry. Most of the initial impact of these partnerships will likely be in implantable devices, but the longer-term effects may be stronger in data systems that integrate and reinforce planning platforms.
- China Localization: Price cuts for certain hip and knee devices in 2025 due to a shift to local production created greater competition in hip and knee replacements in areas not controlled by the same purchasing.
Adding outpatient facilities as a focus will require further rationalization of implant portfolio lines. Consolidation is likely, especially due to pricing pressures. Orthopedic implants may remain safe from pricing pressures for more complex procedures and technology-enabled surgery.
Strategic Growth Opportunities in the Orthopedic Device Market
The Orthopedic Devices market is expected to move beyond implant volume toward outcome-based care, outpatient procedures and data-driven personalization between 2024 and 2026. Various factors such as an aging population, sports-related injuries, staff shortages in the hospital workforce, and decreased reimbursement are expanding market opportunities. Lucintel's market perspective indicates that suppliers integrating clinical data with lean manufacturing will gain market share.
- Robotic and Digital Surgery: Navigation is expanding from lower extremities into the spine and traumas. In 2024, Stryker reported sales of $22.6 billion, representing continued strong demand for surgical technologies. In the next three to five years, integrated systems with software will be the focus of investment because of their potential to support the training of surgeons and to offer precision and ambulatory care.
- Additive-manufactured Implants: Complex revisions require specialized implants. Standard geometry can't always address these challenges. Patient-specific design can. Titanium can be used for patient-specific implants through AM. The FDA has cleared more than 100 3D-printed medical devices. Hospitals are starting to favor devices that promote better anatomical fits and shorter revision pathways. They also want to provide premium differentiated products.
- Outpatient Orthopaedic Care: Ambulatory surgery centres (ASCs) are taking joint procedures from hospitals. This shift has created a demand for smaller instrumentation and implant systems. In 2000, there were 1,740 procedures on Medicare's inpatient-only list. As of April 2025, that number was 267. Any supplier that can speed up turnaround time for a facility will gain competitive advantage.
- Emerging-market Access: There is untapped potential in various regions like Latin America, the Middle East, and Southeast Asia. As population health improvements and increased insurance coverage strengthen specialist capacity in these markets, localized products with different prices and distribution will help ensure long-term growth. For example, India's Union Budget for 2025-26 allocated ₹98,311 crore to health and family welfare.
- Implant Lifecycle Services: Hospitals are moving away from one-time purchase of medical devices and are requiring the refurbishment of medical devices, optimization of medical device inventory and digital tracking. As of March 2025, the FDA's UDI database had more than 7 million records of medical devices. Margin-eroding service contracts will be more favorable than fixed-price product contracts, as they will enable better utilization, traceability, and reorder visibility.
The strongest prospects will sit where implant design, data and care delivery integration meet. Novelty will not be the main factor in determining commercial success of a product, rather the evidence supporting surgeons, payers and procurement teams will. Despite this, regional partnerships will be key, particularly where the orthopedic regulatory and capacity differ. As such, a product portfolio should consist of a premium system, supported by less advanced systems. The next cycle belongs to companies that measure and reduce anatomic revision rates and overall procedure time. Companies should also focus on reducing patient recovery time. The next cycle also belongs to companies with the best integration of implants and data in order to solve anatomic and workflow problems.
Orthopedic Device Market Drivers and Challenges
The orthopedic device market is primarily impacted by factors such as population aging, growing rates of injury and disease, changing regulations and policies, and healthcare spending. There is increasing demand for a variety of products including implants, surgical instruments, and digital products. Other factors, such as economic conditions, reimbursement policies, the supply chain, and sustainability, affect how orthopedic devices are adopted. According to Lucintel, the long-term direction of the market will be determined by innovation, clinical outcomes, and manufacturing.
The factors responsible for driving this market include:
- Continued Development of New Technologies: The use of robotics, AI and connected devices in surgery is improving the accuracy of surgical procedures and assisting in patient recovery. Hospitals further expanded robotic-assisted orthopedic surgeries in January 2025, with several robotic systems assisting thousands of joint replacement surgeries annually. Personalized implants, reduced surgery complication rates and improved efficiency in the orthopedic operating room will likely increase adoption of these technologies in both elective and non-elective surgeries over the next three to five years. However, providers will demand evidence of improved outcomes in order to make large purchases.
- Aging and Chronic Conditions: Population aging increases the incidence of conditions such as osteoarthritis, osteoporosis and other degenerative conditions of the spine which often result in fractures. The global population over the age of 65 continued to be over 800 million in 2025, increasing the patient population requiring joint reconstruction and fracture management. Additionally, there is a growing demand for durable implants, especially if the patient is expected to live a long time. Over the next three to five years, the increase in the aging population will create additional opportunities for the orthopedic device market.
- Product Innovation: Improvements in biomaterials, patient-specific implants, absorbable fixation products, advanced coatings, and minimally-invasive instrumentation have been seen in the market. In 2025, additive manufacturing continued producing patient-specific titanium orthopedic implants for complex cases. In the coming three to five years, innovation will expand the market by creating new, high-end product tiers to address more challenging clinical indications. Premium products, coupled with adequate clinical evidence, reliable manufacturing, and training of the surgical community will foster market success.
- Healthcare Infrastructure Investment: Investments in orthopedic hospitals, ambulatory surgery centres, rehabilitation centres, and diagnostics increase access to care. Some emerging markets in 2025 continued to build out their imaging and OR capacity in order to better address the surgical backlog. Improved infrastructure allows for the use of more advanced implants and navigation systems, and helps shorten wait times. Improved infrastructure will allow the market to expand beyond major urban centres. Equipment alone, however, will not be the only challenge, particularly in the near term. Dependable supply and maintenance of the equipment, as well as adequate reimbursement and trained personnel will be critical.
- Manufacturing Efficiency and Cost Advantages: Digital design, automation, regional production, and improved procurement have all helped reduce manufacturing costs and waste. In March 2025, the use of automated quality control systems to improve consistency in the production of implants became commonplace, and costs continue to fall. Lower costs may expand the availability of essential medical devices, preserve margins in the face of price cuts, and facilitate value-based purchasing. Manufacturers able to cut costs and improve efficiency are expected to gain the most market share over the next 3 to 5 years. There may also be a reduction in the Transportation Risks associated with local production, but Final Market prices may still be impacted by raw material costs and the compliance and validation processes.
The challenges facing this market include:
- Procedural and Device Costs: Expenses related to advanced medical devices and implants, as well as the procedures to use them, burden both patients and hospitals. Many Healthcare Providers postponed capital purchases in 2025 due to elevated borrowing costs, constrained operating budgets, and increased economic uncertainty. Cost-effectiveness may impact adoption of new medical devices, especially in less developed markets and smaller hospitals. Manufacturers will have to demonstrate total economic value by reducing the length of stay and enhancing the quality of outcomes in the next 3 to 5 years. Product leasing, tiered pricing, and value-based contracts may improve affordability, but limitations will remain.
- Regulatory and Reimbursement Complexity: There are differences in the standards for the safety and efficacy of devices in different countries. Regulators also strengthened their expectations for clinical evidence, including cyber security and long-term monitoring of implantable devices, in 2025. All of these aspects increase the cost and time required for the development and commercialization of orthopedic devices. Further, uncertainty in reimbursement decisions can discourage physician adoption of a device, even if it has received regulatory clearance. Orthopedic device manufacturers who are best positioned to quickly and efficiently create clinical evidence and navigate the regulatory environment are expected to be more successful in the next 3-5 years.
- Supply-Chain and Skilled Labor Constraints: Orthopedic devices are made with specialty metals and polymers, thin coatings, and require precision machining and sterilization. Personnel in the orthopedic industry are considered to be highly skilled. Manufacturers of orthopedic devices continued to diversify their supplier bases in 2025 after being affected by disruptions to their medical device logistics.
When it comes to the orthopedic device industry, in the next three to five years the trend will be towards regional sourcing, digital inventory, dual sourcing, and workforce development.
Because of the on-going developments in the field of orthopedics and the global population aging, the demand for orthopedic devices will continue to grow. The same advances in the field may lead to new developments in orthopedic devices and procedures. Orthopedic procedures have the potential to improve patients' quality of life and increase longevity. Improving access to advanced procedures has the potential to significantly benefit a patient population which has previously had very limited treatment options. However, many barriers will need to be removed in order for this potential to be realized.
List of Orthopedic Device Market Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies orthopedic device market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the orthopedic device market companies profiled in this report include-
- Zimmer Biomet Holdings
- Medtronic
- Wright Medical Group
- Smith & Nephew
- Stryker Corporation
- RTI Surgical
- Arthrex
Orthopedic Device Market by Segment
The study includes a forecast for the global orthopedic device market by type, application, and region.
Orthopedic Device Market by Type [Value ($M) from 2019 to 2035]:
- Joint Reconstruction
- Spinal Devices
- Trauma Fixation Devices
- Arthroscopic Devices
- Orthopedic Accessories
- Others
Orthopedic Device Market by Application [Value ($M) from 2019 to 2035]:
- Hip
- Knee
- Spine
- Dental
- Craniomaxillofacial
- Others
Orthopedic Device Market by Region [Value ($M) from 2019 to 2035]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Country Wise Outlook for the Orthopedic Device Market
The orthopedic device market has experienced significant growth driven by technological advancements, aging populations, and increasing prevalence of musculoskeletal conditions worldwide. Countries are investing heavily in innovation, regulatory approvals, and expanding healthcare infrastructure to meet rising demand. The United States remains a leader in research and development, while China is rapidly expanding its manufacturing capabilities. Germany emphasizes high-quality, precision devices, and India and Japan are focusing on affordable solutions and technological integration. These developments reflect a global shift towards personalized, minimally invasive, and technologically advanced orthopedic solutions, shaping the future landscape of the market.
- United States: The US orthopedic device market has seen substantial innovation, with increased adoption of minimally invasive procedures and advanced materials like bioresorbable implants. Major players are investing in R&D for smart devices integrated with digital health technologies. Regulatory pathways have become more streamlined, encouraging faster product launches. The aging population and rising sports injuries continue to drive demand. Telemedicine and 3D printing are also gaining traction, enhancing customization and patient outcomes. Overall, the US market remains highly competitive, with a focus on technological integration and patient-centric solutions.
- China: China's orthopedic device market is rapidly expanding, fueled by government initiatives to modernize healthcare infrastructure and a large, aging population. Local manufacturers are increasing their R&D efforts, producing cost-effective, innovative devices to meet domestic demand. The country is also becoming a significant exporter of orthopedic products. Technological advancements such as 3D printing and robotic-assisted surgeries are gaining popularity. Regulatory reforms are facilitating faster approvals, encouraging foreign investment. The focus is on affordable, high-quality devices that cater to a growing middle class seeking advanced orthopedic care. China's market is poised for substantial growth in the coming years.
- Germany: Germany emphasizes high-quality, precision orthopedic devices, leveraging its strong engineering and manufacturing expertise. The market is characterized by innovative products such as customized implants and smart prosthetics. Germany's strict regulatory standards ensure safety and efficacy, fostering trust among healthcare providers. The country is also investing in digital health integration, including AI-driven diagnostics and robotic surgeries. Collaboration between academia and industry is prominent, promoting cutting-edge research. The aging population and increasing prevalence of osteoarthritis are key drivers. Germany's focus on sustainability and eco-friendly manufacturing practices is also shaping its market development.
- India: India's orthopedic device market is witnessing rapid growth due to increasing healthcare access, rising awareness, and a large patient base. The focus is on affordable, durable devices suitable for a diverse population. Local manufacturers are expanding their R&D capabilities to develop cost-effective solutions, including implants and surgical instruments. Government initiatives to improve healthcare infrastructure and promote medical tourism are boosting demand. Technological integration, such as minimally invasive techniques and digital imaging, is gaining importance. The market is also seeing increased adoption of innovative materials and techniques to improve patient outcomes. Overall, India is emerging as a significant player in the global orthopedic device landscape.
- Japan: Japan's orthopedic device market is driven by an aging population and a high prevalence of osteoporosis and joint disorders. The country emphasizes advanced, minimally invasive surgical solutions and robotic-assisted procedures. Japanese companies are known for their high-quality, innovative implants and prosthetics, often incorporating cutting-edge materials. The government supports research and development through grants and regulatory incentives. Digital health integration, including wearable devices and tele-rehabilitation, is expanding. Japan's focus on precision medicine and personalized treatment options is shaping its market. The country's strong healthcare infrastructure and technological expertise position it as a key player in the global orthopedic device industry.
Features of the Global Orthopedic Device Market
- Market Size Estimates: orthopedic device market size estimation in terms of value ($M).
- Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
- Segmentation Analysis: orthopedic device market size by type, application, and region in terms of value ($M).
- Regional Analysis: orthopedic device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the orthopedic device market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the orthopedic device market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
This report answers following 11 key questions:
- Q.1. What are some of the most promising, high-growth opportunities for the orthopedic device market by type (joint reconstruction, spinal devices, trauma fixation devices, arthroscopic devices, orthopedic accessories, and others), application (hip, knee, spine, dental, craniomaxillofacial, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- Q.2. Which segments will grow at a faster pace and why?
- Q.3. Which region will grow at a faster pace and why?
- Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- Q.5. What are the business risks and competitive threats in this market?
- Q.6. What are the emerging trends in this market and the reasons behind them?
- Q.7. What are some of the changing demands of customers in the market?
- Q.8. What are the new developments in the market? Which companies are leading these developments?
- Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?